GSE186177
Genome wide expression change by C4-2 cells treated with MST1/2 inhibitor XMU-MP-1
We aim to the investigate the role of MST1/2 inhibitor XMU-MP-1 in prostate cancer progression. C4-2 cells were used as the model. Overall design: The C4-2 cells were treated with vehicle or 3 µM XMU-MP-1 . After 6 hours, cells were harvested and the total RNA was extacted by Qiagen kit. The RNA sample was sent to BGI for RNA expression anaylsis.